EMDR

Eye Movement Desensitization and Reprocessing EMDR is an FDA-approved psychotherapy developed by Dr. Francine Shapiro in 1987 that uses bilateral sensory stimulation most commonly guided eye movements but also alternating auditory tones or tapping to process and integrate traumatic memories that remain maladaptively stored in the nervous system. EMDR is currently recommended by the World Health Organization WHO the American Psychiatric Association APA and the U.S. Department of Veterans Affairs for PTSD treatment. The neurological mechanism documented in NIH research PMC6106867 is multifaceted bilateral stimulation during EMDR suppresses amygdala activity reducing the emotional charge of traumatic memories activates the anterior cingulate cortex emotion regulation and mimics the neurological processes of REM sleep the phase during which the brain naturally processes emotionally charged experiences. Eye movements specifically activate cholinergic systems and inhibit sympathetic nervous system activation creating a physiological window for trauma reprocessing that bypasses the typical freeze or avoidance response. EMDR operates on the Adaptive Information Processing AIP model which posits that psychological distress results from improperly stored memories that activate as if the original threat is present. Bilateral stimulation during memory recall allows the brain to reprocess the memory with updated context reducing its autonomic charge. Studies show EMDR produces symptom relief in 6 to 12 sessions for single-incident PTSD significantly faster than traditional CBT. In 2026 EMDR has expanded beyond clinical PTSD treatment into anxiety disorders phobias and performance optimization with digital EMDR apps and remote therapist-guided sessions widening access substantially across 40 percent of the global population experiencing daily anxiety.